Consulta’s AB InBev BUD Stock Holding History

Consulta’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-750,000	Closed	-$42.5M	–	14
2023 Q2	$42.5M	Hold	750,000	–	–	2.96%	13
2023 Q1	$50M	Hold	750,000	–	–	3.94%	13
2022 Q4	$45M	Buy	+750,000	New	+$40.3M	3.86%	12

Other funds holding BUD

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Gates Foundation Trust Kirkland, Washington $34.4B AUM 26.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Consulta's BUD Position: Q3 2023 in Review

Consulta sold out of AB InBev (BUD) in Q3 2023, closing a stake of 750,000 shares — an estimated $42.5M sold.

Consulta first reported a position in BUD in Q4 2022 and held it in 3 quarters. The position peaked at $50M in Q1 2023. 479 funds tracked by Wall St. Rank hold BUD as of Q3 2023.

Consulta reported no remaining AB InBev position as of Q3 2023 after selling out during the quarter.
Consulta sold 750,000 AB InBev shares in Q3 2023, an estimated $42.5M.
Consulta first reported a position in AB InBev in Q4 2022 and held it in 3 quarters.
Consulta's AB InBev position peaked at $50M in Q1 2023.
479 funds tracked by Wall St. Rank held AB InBev as of Q3 2023.

Based on Consulta's 13F filing for Q3 2023, filed 14 Nov 2023.